Log in or Sign up for Free to view tailored content for your specialty!
Neurology News
Conscious sedation no better than general anesthesia in post-stroke endovascular treatment
Conscious sedation was not superior to general anesthesia for functional recovery in patients undergoing endovascular treatment following acute posterior circulation stroke, researchers reported in JAMA Neurology.
Healthy habits in midlife may help delay onset of cognitive decline
LAS VEGAS — To slow or stave off symptoms relating to Alzheimer’s disease and dementia, individuals should make healthy habits a priority early in life, according to a presenter at BRAINWeek 2022.
Log in or Sign up for Free to view tailored content for your specialty!
PD therapy for off time depends on safety, efficacy, patient preference
LAS VEGAS — When evaluating the best choice for on-demand therapies for off time in Parkinson’s disease, physicians should consider severity of side effects, time to efficacy and patient preference, a presenter stated at BRAINWeek 2022.
Phase 3 study of lecanemab shows reduction in clinical decline in patients with early AD
Pharmaceutical companies Biogen and Eisai announced results from a phase 3 trial that demonstrated treatment with lecanemab reduced cognitive decline by 27% after 18 months compared with placebo.
International Parkinson’s study to explore risk prediction of neurodegenerative diseases
The National Center of Excellence in Research on Parkinson’s Disease in Luxembourg has launched an online survey in collaboration with regional research centers to improve risk prediction for neurodegenerative diseases.
Monkeypox should be considered in high-risk populations with neurologic symptoms
Monkeypox should be considered in high-risk populations who present with neurologic symptoms, warranting the need for serology and PCR testing of blood and spinal fluid, researchers wrote in JAMA Neurology.
Majority of small business owners prioritize mental health since onset of pandemic
Results of a recently released poll revealed that 77% of small business owners said they have prioritized mental health since the onset of the COVID-19 pandemic.
Rituximab reduced risk for disease worsening in generalized myasthenia gravis
A single, 500 mg dose of rituximab was associated with greater probability of minimal myasthenia gravis manifestations and reduced the need for rescue medications compared with placebo, researchers reported in JAMA Neurology.
Multimorbidity associated with increased risk for dementia
Multimorbidity was associated with a 63% increased risk for incident dementia, with the greatest risk linked to hypertension and diabetes, researchers reported in JAMA Network Open.
NIH awards UCLA $10M to study brain’s cellular infrastructure
The NIH has awarded nearly $10 million to two scientists at UCLA’s David Geffen School of Medicine for research projects that aim to shed light on the development of the brain’s cellular infrastructure as well as brain disorders.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read